Europe Radiopharmaceuticals Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 3,487.24 |
 CAGR |
% |
| Major Markets Players |
>欧洲放射性药物市场，按类型（诊断放射性药物和治疗放射性药物）、应用（诊断和治疗）、来源（核反应堆和回旋加速器）、最终用户（医院、诊断中心、癌症研究机构、门诊手术中心等）划分 - 行业趋势和预测到 2030 年。
欧洲放射性药物市场分析与洞察
欧洲对放射性药物的认识不断提高，增强了市场需求。为获得更好的医疗服务而增加的医疗支出也促进了市场的增长。在这一关键时期，主要市场参与者专注于各种服务的推出和批准。此外，药物开发技术的进步也促进了对放射性药物的需求。
由于市场参与者的增加和先进服务的可用性，欧洲放射性药物市场预计将增长。与此同时，制造商正致力于开发活动，以在市场上推出新服务。药物开发领域的不断增长进一步推动了市场的增长。然而，缺乏标准化协议和缺乏熟练专业人员等困难预计将抑制市场增长。
医疗保健在进步和药物开发方面的支出不断增加，预计将为市场带来机遇。然而，替代疗法的日益普及可能会对市场增长构成挑战。
Data Bridge Market Research 分析称，到 2030 年，欧洲放射性药物市场价值预计将达到 34.8724 亿美元，2023-2030 年预测期内的复合年增长率为 5.9%。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史性的一年 |
2021（可定制为 2015 – 2020） |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
类型（诊断放射性药物和治疗放射性药物）、应用（诊断和治疗）、来源（核反应堆和回旋加速器）、最终用户（医院、诊断中心、癌症研究机构、门诊手术中心等） |
|
覆盖国家 |
德国、英国、法国、意大利、西班牙、比利时、波兰、俄罗斯、挪威、土耳其、奥地利、爱尔兰、匈牙利、荷兰、瑞士和欧洲其他地区 |
|
涵盖的市场参与者 |
Cardinal Health、Advanced Accelerator Applications（诺华公司旗下）、Lantheus、CURIUM、Jubilant Radiopharma（Jubilant Pharmova 公司旗下）、中国同位素辐照有限公司、西门子医疗有限公司、Bracco、Eckert & Ziegler、SHINE Technologies, LLC、IBA Worldwide、同位素研究所等 |
欧洲放射性药物市场定义
放射性药物含有放射性物质以及一种或多种成分，用于诊断、确定疾病阶段、监测治疗或提供治疗。放射性药物包括一组用于诊断或治疗干预的放射性药剂。这些药物含有放射性核素。大多数放射性药物是放射性核素或放射性核素与作为载体并决定定位和生物分布的生物活性分子或药物的组合。
欧洲放射性药物市场动态
本节旨在了解市场驱动因素、机遇、限制因素和挑战。下文将详细讨论所有这些内容：
司机
- 诊断和临床应用对放射性药物的需求日益增长
放射性药物已成为帮助诊断器官和治疗病理疾病的必不可少的药物。它们用于诊断成像和放射治疗。诊断放射性药物不具有药理作用，并且其给药也不被认为与相关的临床副作用有关。
临床使用的放射性药物数量正在迅速增加，从而使医学界能够更好地获取有关不同类型肿瘤特征的详细信息。放射性核素也因对越来越多的恶性疾病提供姑息和治愈治疗而变得越来越重要。
机会
- 放射性药物研发费用不断上升
技术进步包括提高传统药物的稳定性和强度。生物技术和制药公司不断投资于研发，为客户提供诊断和药物的创新服务，并提高其市场占有率。放射性药物在临床开发中发挥着积极作用。尽管诊断行业由于新技术在市场上的实施而处于不断波动的状态，但制药和生物技术行业继续增长，这是因为放射性药物公司的投资增加以及并购采用成像技术的创新来支持各种疾病的临床试验。
制药和生物技术公司不断增加的研发支出为欧洲放射性药物市场的增长提供了机遇。
限制/挑战
- 放射性药物的严格规定
放射性药物是用于诊断某些医疗问题或治疗某些疾病的药剂。因此，政府对将产品推向市场的各种监管规定被认为是一大制约因素。每个国家都有自己的法规，并且有不同的机构负责监管程序。严格的监管和产品审批政策预计将阻碍放射性药物市场的发展。
政府部门的严格监管对于维护公司声誉、防止产品不可靠以及增加消费者信任度是必要的。新药获得监管机构的批准需要经过几个阶段的投资和测试，而新药又包含多个阶段，每个阶段都有不同的监管要求。
进行试验的组织需要遵守有关国家特定监管机构所要求的文件，并且应根据该国的政策和管辖权确保其安全性和合法性。
然而，市场上对放射性药物进行监管的严格监管准则可能会阻碍市场增长，而由于复杂的监管而导致药物从市场上撤出可能会对市场产生负面影响，预计会抑制市场增长。
- 放射性药物的开发和实施成本高昂
放射性药物在医疗机构中发挥着重要作用，为制药和生物技术公司提供安全性和效率。它们具有优异的性能，但同时也存在一些缺点。由于技术的进步，放射性药物预计将增长。然而，由于放射性药物的开发和实施成本高昂，市场可能不会迅速扩张，因此一些障碍可能会阻碍市场充分发挥其潜力。因此，更高的开发和实施成本以及对合适表面的要求限制了市场的增长，导致额外的基础设施和运营成本。
最新动态
- 2023年10月，IBA在巴塞罗那的各场会议上推出了心脏PET成像综合解决方案AKURACY。该公司相信并表示，这是PET心肌灌注成像独一无二的综合解决方案。
- 2023 年 4 月，Lantheus 和 POINT Biopharma 宣布 FDA 授予 ¹⁷⁷Lu-PNT2002 快速通道资格，用于治疗转移性去势抵抗性前列腺癌。该公司表示，放射性配体疗法正迅速成为癌症治疗的另一个支柱。
欧洲放射性药物市场范围
欧洲放射性药物市场分为四个显著的细分市场，例如类型、应用、来源和最终用户。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
类型
- 诊断放射性药物
- 治疗性放射性药物
根据类型，市场分为诊断放射性药物和治疗放射性药物。
应用
- 诊断
- 治疗
根据应用，市场分为诊断和治疗。
来源
- 核反应堆
- 回旋加速器
根据来源，市场分为核反应堆和回旋加速器。
最终用户
- 医院
- 诊断中心
- 癌症研究机构
- 门诊手术中心
- 其他的
根据最终用户，市场分为医院、诊断中心、癌症研究机构、门诊手术中心和其他。
欧洲放射性药物市场区域分析/见解
欧洲放射性药物市场分为类型、应用、来源和最终用户四个显著的部分。
本市场报告涵盖的国家包括德国、英国、法国、意大利、西班牙、比利时、波兰、俄罗斯、挪威、土耳其、奥地利、爱尔兰、匈牙利、荷兰、瑞士和欧洲其他地区。
由于德国在医疗保健领域的投资不断增加，预计将主导市场，这有望促进市场增长。由于医疗保健和治疗产品的技术进步，预计德国将主导欧洲地区。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战，以及销售渠道的影响。
竞争格局和欧洲放射性药物市场份额分析
欧洲放射性药物市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品批准、产品宽度和广度、应用主导地位以及产品类型生命线曲线。以上提供的数据点仅与公司对市场的关注有关。
欧洲放射性药物市场的一些主要市场参与者包括 Cardinal Health、Advanced Accelerator Applications（诺华公司旗下子公司）、Lantheus、CURIUM、Jubilant Radiopharma（Jubilant Pharmova 公司旗下子公司）、中国同位素与辐照有限公司、西门子医疗有限公司、Bracco、Eckert & Ziegler、SHINE Technologies, LLC、IBA Worldwide、同位素研究所等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE RADIOPHARMACEUTICALS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET TESTING TYPE COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 PIPELINE ANALYSIS
4.4 PATENT ANALYSIS
4.5 DRUG TREATMENT RATE BY MATURED MARKETS
4.6 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES
4.7 PATIENT FLOW DIAGRAM
4.8 KEY PRICING STRATEGIES
4.9 KEY PATIENT ENROLLMENT STRATEGIES
5 LIST OF CYCLOTRONS
5.1 EUROPE
6 REGULATORY SCENARIO
6.1 EUROPE
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 THE GROWING DEMAND FOR RADIOPHARMACEUTICALS IN DIAGNOSTICS AND CLINICAL USE
7.1.2 THE INCREASING NEED FOR PHARMACEUTICAL PRODUCTS ACROSS VARIED THERAPEUTIC AREAS
7.1.3 THE INCREASING PREVALENCE OF CHRONIC DISEASES
7.2 RESTRAINTS
7.2.1 STRINGENT REGULATIONS FOR RADIOPHARMACEUTICALS
7.2.2 POTENTIAL RISKS ASSOCIATED WITH RADIOPHARMACEUTICALS
7.3 OPPORTUNITIES
7.3.1 THE RISING RESEARCH AND DEVELOPMENT EXPENDITURE OF RADIOPHARMACEUTICALS
7.3.2 THE GROWING INCIDENCES OF COMPLEX DISEASES IN GERIATRIC POPULATION
7.4 CHALLENGES
7.4.1 HIGH COST OF DEVELOPMENT AND IMPLEMENTATION OF RADIOPHARMACEUTICALS
7.4.2 LACK OF TECHNICAL EXPERTISE AND HIGH COST FOR TRAINING EXISTING WORKFORCE
8 EUROPE RADIOPHARMACEUTICALS MARKET, BY TYPE
8.1 OVERVIEW
8.2 DIAGNOSTIC RADIOPHARMACEUTICALS
8.2.1 PET RADIOPHARMACEUTICALS
8.2.1.1 F-18
8.2.1.2 RU-82
8.2.1.3 OTHER PET ISOTOPES RADIOPHARMACEUTICALS
8.2.2 SPECT RADIOPHARMACEUTICALS
8.2.2.1 TECHNETIUM-99M
8.2.2.2 GALLIUM-67
8.2.2.3 IODINE-123
8.2.2.4 THALLIUM-201
8.2.2.5 OTHER SPECT ISOTOPES
8.3 THERAPEUTIC RADIOPHARMACEUTICALS
8.3.1 BRACHYTHERAPY ISOTOPES
8.3.1.1 IODINE-125
8.3.1.2 PALLADIUM-103
8.3.1.3 CESIUM-131
8.3.1.4 IRIDIUM-192
8.3.1.5 OTHER BRACHYTHERAPY ISOTOPES
8.3.2 BETA EMITTERS
8.3.2.1 IODINE-131
8.3.2.2 LUTHETIUM-177
8.3.2.3 SAMARIUM-153
8.3.2.4 YTTRIUM-90
8.3.2.5 RHENIUM-186
8.3.2.6 OTHER BETA EMITTERS
8.3.3 ALPHA EMITTERS
8.3.3.1 RA-223
8.3.3.2 OTHERS
9 EUROPE RADIOPHARMACEUTICALS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DIAGNOSTIC
9.2.1 PET
9.2.1.1 ONCOLOGY
9.2.1.2 CARDIOLOGY
9.2.1.3 NEUROLOGY
9.2.1.4 OTHER PET APPLICATION
9.2.2 SPECT
9.2.2.1 CARDIOLOGY
9.2.2.2 BONE SCANS
9.2.2.3 THYROID APPLICATIONS
9.2.2.4 PULMONARY SCANS
9.2.2.5 OTHER SPECT APPLICATION
9.3 THERAPEUTIC
9.3.1 THYROID INDICATIONS
9.3.2 BONE METASTASIS
9.3.3 LYMPHOMA
9.3.4 ENDOCRINE TUMORS
9.3.5 OTHER INDICATIONS
10 EUROPE RADIOPHARMACEUTICALS MARKET, BY SOURCE
10.1 OVERVIEW
10.2 NUCLEAR REACTORS
10.3 CYCLOTRONS
11 EUROPE RADIOPHARMACEUTICALS MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 DIAGNOSTIC CENTERS
11.4 CANCER RESEARCH INSTITUTES
11.5 AMBULATORY SURGICAL CENTERS
11.6 OTHERS
12 EUROPE RADIOPHARMACEUTICAL MARKET
12.1 EUROPE
12.1.1 GERMANY
12.1.2 U.K.
12.1.3 FRANCE
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 BELGIUM
12.1.7 POLAND
12.1.8 RUSSIA
12.1.9 NORWAY
12.1.10 TURKEY
12.1.11 AUSTRIA
12.1.12 IRELAND
12.1.13 HUNGARY
12.1.14 NETHERLANDS
12.1.15 SWITZERLAND
12.1.16 REST OF EUROPE
13 COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 CARDINAL HEALTH
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 ADVANCED ACCELERATOR APPLICATIONS, A NOVARTIS COMPANY
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 LANTHEUS
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 CURIUM
15.4.1 COMPANY SNAPSHOT
15.4.2 COMPANY SHARE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENT
15.5 GENERAL ELECTRIC COMPANY
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 BRACCO
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENT
15.7 CHINA ISOTOPE & RADIATION CORPORATION
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 ECKERT & ZIEGLER
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENT
15.9 IBA WORLDWIDE
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENT
15.1 INSTITUTE OF ISOTOPES
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 JUBILANT RADIOPHARMA A JUBILANT PHARMOVA COMPANY
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 SHINE TECHNOLOGIES, LLC
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 SIEMENS HEALTHCARE GMBH
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 EUROPE RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 2 EUROPE DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 3 EUROPE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 4 EUROPE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 5 EUROPE THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 6 EUROPE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 EUROPE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 8 EUROPE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 9 EUROPE RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 10 EUROPE DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 11 EUROPE PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 EUROPE SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 13 EUROPE THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 14 EUROPE RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 15 EUROPE RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 16 EUROPE RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 17 EUROPE RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 18 EUROPE DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 19 EUROPE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 20 EUROPE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 21 EUROPE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 22 EUROPE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 23 EUROPE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 24 EUROPE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 25 EUROPE THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 26 EUROPE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 27 EUROPE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 28 EUROPE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 29 EUROPE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 30 EUROPE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 31 EUROPE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 32 EUROPE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 33 EUROPE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 34 EUROPE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 35 EUROPE RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 36 EUROPE DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 37 EUROPE PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 38 EUROPE SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 39 EUROPE THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 40 EUROPE RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 41 EUROPE RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 42 GERMANY RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 43 GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 44 GERMANY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 45 GERMANY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 46 GERMANY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 47 GERMANY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 48 GERMANY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 49 GERMANY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 50 GERMANY THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 51 GERMANY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 52 GERMANY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 53 GERMANY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 54 GERMANY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 55 GERMANY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 56 GERMANY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 57 GERMANY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 58 GERMANY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 59 GERMANY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 60 GERMANY RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 61 GERMANY DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 62 GERMANY PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 63 GERMANY SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 64 GERMANY THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 65 GERMANY RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 66 GERMANY RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 67 U.K. RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 68 U.K. DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 69 U.K. PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 70 U.K. PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 71 U.K. PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 72 U.K. SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 73 U.K. SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 74 U.K. SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 75 U.K. THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 76 U.K. BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 U.K. BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 78 U.K. BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 79 U.K. BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 U.K. BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 81 U.K. BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 82 U.K. ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 83 U.K. ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 84 U.K. ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 85 U.K. RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 86 U.K. DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 87 U.K. PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 U.K. SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 89 U.K. THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 90 U.K. RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 91 U.K. RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 92 FRANCE RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 93 FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 94 FRANCE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 95 FRANCE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 96 FRANCE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 97 FRANCE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 98 FRANCE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 99 FRANCE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 100 FRANCE THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 FRANCE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 FRANCE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 103 FRANCE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 104 FRANCE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 105 FRANCE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 106 FRANCE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 107 FRANCE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 108 FRANCE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 109 FRANCE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 110 FRANCE RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 111 FRANCE DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 112 FRANCE PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 113 FRANCE SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 114 FRANCE THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 115 FRANCE RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 116 FRANCE RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 117 ITALY RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 118 ITALY DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 119 ITALY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 120 ITALY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 121 ITALY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 122 ITALY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 123 ITALY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 124 ITALY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 125 ITALY THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 126 ITALY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 ITALY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 128 ITALY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 129 ITALY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 ITALY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 131 ITALY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 132 ITALY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 133 ITALY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 134 ITALY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 135 ITALY RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 136 ITALY DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 137 ITALY PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 138 ITALY SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 139 ITALY THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 140 ITALY RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 141 ITALY RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 142 SPAIN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 143 SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 144 SPAIN PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 145 SPAIN PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 146 SPAIN PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 147 SPAIN SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 148 SPAIN SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 149 SPAIN SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 150 SPAIN THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 151 SPAIN BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 152 SPAIN BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 153 SPAIN BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 154 SPAIN BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 155 SPAIN BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 156 SPAIN BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 157 SPAIN ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 158 SPAIN ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 159 SPAIN ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 160 SPAIN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 161 SPAIN DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 162 SPAIN PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 163 SPAIN SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 164 SPAIN THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 165 SPAIN RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 166 SPAIN RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 167 BELGIUM RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 168 BELGIUM DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 169 BELGIUM PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 170 BELGIUM PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 171 BELGIUM PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 172 BELGIUM SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 173 BELGIUM SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 174 BELGIUM SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 175 BELGIUM THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 176 BELGIUM BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 177 BELGIUM BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 178 BELGIUM BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 179 BELGIUM BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 180 BELGIUM BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 181 BELGIUM BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 182 BELGIUM ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 183 BELGIUM ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 184 BELGIUM ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 185 BELGIUM RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 186 BELGIUM DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 187 BELGIUM PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 188 BELGIUM SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 189 BELGIUM THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 190 BELGIUM RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 191 BELGIUM RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 192 POLAND RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 193 POLAND DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 194 POLAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 195 POLAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 196 POLAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 197 POLAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 198 POLAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 199 POLAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 200 POLAND THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 201 POLAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 202 POLAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 203 POLAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 204 POLAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 205 POLAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 206 POLAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 207 POLAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 208 POLAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 209 POLAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 210 POLAND RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 211 POLAND DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 212 POLAND PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 213 POLAND SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 214 POLAND THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 215 POLAND RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 216 POLAND RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 217 RUSSIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 218 RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 219 RUSSIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 220 RUSSIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 221 RUSSIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 222 RUSSIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 223 RUSSIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 224 RUSSIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 225 RUSSIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 226 RUSSIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 227 RUSSIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 228 RUSSIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 229 RUSSIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 230 RUSSIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 231 RUSSIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 232 RUSSIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 233 RUSSIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 234 RUSSIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 235 RUSSIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 236 RUSSIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 237 RUSSIA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 238 RUSSIA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 239 RUSSIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 240 RUSSIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 241 RUSSIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 242 NORWAY RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 243 NORWAY DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 244 NORWAY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 245 NORWAY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 246 NORWAY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 247 NORWAY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 248 NORWAY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 249 NORWAY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 250 NORWAY THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 251 NORWAY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 252 NORWAY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 253 NORWAY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 254 NORWAY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 255 NORWAY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 256 NORWAY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 257 NORWAY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 258 NORWAY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 259 NORWAY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 260 NORWAY RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 261 NORWAY DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 262 NORWAY PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 263 NORWAY SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 264 NORWAY THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 265 NORWAY RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 266 NORWAY RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 267 TURKEY RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 268 TURKEY DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 269 TURKEY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 270 TURKEY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 271 TURKEY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 272 TURKEY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 273 TURKEY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 274 TURKEY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 275 TURKEY THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 276 TURKEY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 277 TURKEY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 278 TURKEY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 279 TURKEY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 280 TURKEY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 281 TURKEY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 282 TURKEY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 283 TURKEY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 284 TURKEY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 285 TURKEY RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 286 TURKEY DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 287 TURKEY PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 288 TURKEY SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 289 TURKEY THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 290 TURKEY RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 291 TURKEY RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 292 AUSTRIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 293 AUSTRIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 294 AUSTRIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 295 AUSTRIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 296 AUSTRIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 297 AUSTRIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 298 AUSTRIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 299 AUSTRIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 300 AUSTRIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 301 AUSTRIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 302 AUSTRIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 303 AUSTRIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 304 AUSTRIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 305 AUSTRIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 306 AUSTRIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 307 AUSTRIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 308 AUSTRIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 309 AUSTRIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 310 AUSTRIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 311 AUSTRIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 312 AUSTRIA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 313 AUSTRIA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 314 AUSTRIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 315 AUSTRIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 316 AUSTRIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 317 IRELAND RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 318 IRELAND DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 319 IRELAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 320 IRELAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 321 IRELAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 322 IRELAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 323 IRELAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 324 IRELAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 325 IRELAND THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 326 IRELAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 327 IRELAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 328 IRELAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 329 IRELAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 330 IRELAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 331 IRELAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 332 IRELAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 333 IRELAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 334 IRELAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 335 IRELAND RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 336 IRELAND DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 337 IRELAND PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 338 IRELAND SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 339 IRELAND THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 340 IRELAND RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 341 IRELAND RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 342 HUNGARY RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 343 HUNGARY DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 344 HUNGARY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 345 HUNGARY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 346 HUNGARY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 347 HUNGARY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 348 HUNGARY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 349 HUNGARY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 350 HUNGARY THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 351 HUNGARY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 352 HUNGARY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 353 HUNGARY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 354 HUNGARY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 355 HUNGARY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 356 HUNGARY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 357 HUNGARY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 358 HUNGARY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 359 HUNGARY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 360 HUNGARY RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 361 HUNGARY DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 362 HUNGARY PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 363 HUNGARY SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 364 HUNGARY THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 365 HUNGARY RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 366 HUNGARY RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 367 NETHERLANDS RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 368 NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 369 NETHERLANDS PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 370 NETHERLANDS PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 371 NETHERLANDS PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 372 NETHERLANDS SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 373 NETHERLANDS SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 374 NETHERLANDS SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 375 NETHERLANDS THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 376 NETHERLANDS BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 377 NETHERLANDS BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 378 NETHERLANDS BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 379 NETHERLANDS BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 380 NETHERLANDS BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 381 NETHERLANDS BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 382 NETHERLANDS ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 383 NETHERLANDS ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 384 NETHERLANDS ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 385 NETHERLANDS RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 386 NETHERLANDS DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 387 NETHERLANDS PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 388 NETHERLANDS SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 389 NETHERLANDS THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 390 NETHERLANDS RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 391 NETHERLANDS RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 392 SWITZERLAND RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 393 SWITZERLAND DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 394 SWITZERLAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 395 SWITZERLAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 396 SWITZERLAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 397 SWITZERLAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 398 SWITZERLAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 399 SWITZERLAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 400 SWITZERLAND THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 401 SWITZERLAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 402 SWITZERLAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 403 SWITZERLAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 404 SWITZERLAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 405 SWITZERLAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 406 SWITZERLAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP IN MBQ)
TABLE 407 SWITZERLAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 408 SWITZERLAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)
TABLE 409 SWITZERLAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)
TABLE 410 SWITZERLAND RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 411 SWITZERLAND DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 412 SWITZERLAND PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 413 SWITZERLAND SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 414 SWITZERLAND THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 415 SWITZERLAND RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 416 SWITZERLAND RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 417 REST OF EUROPE RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 EUROPE RADIOPHARMACEUTICALS: SEGMENTATION
FIGURE 2 EUROPE RADIOPHARMACEUTICALS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE RADIOPHARMACEUTICALS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE RADIOPHARMACEUTICALS MARKET: REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE RADIOPHARMACEUTICALS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE RADIOPHARMACEUTICALS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE RADIOPHARMACEUTICALS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE RADIOPHARMACEUTICALS MARKET: MARKET TYPE COVERAGE GRID
FIGURE 9 EUROPE RADIOPHARMACEUTICALS MARKET: SEGMENTATION
FIGURE 10 THE RISING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE EUROPE RADIOPHARMACEUTICALS MARKET IN THE FORECAST PERIOD
FIGURE 11 THE TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE RADIOPHARMACEUTICALS MARKET IN 2023 & 2030
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE RADIOPHARMACEUTICALS MARKET
FIGURE 13 EUROPE RADIOPHARMACEUTICALS MARKET: BY TYPE, 2022
FIGURE 14 EUROPE RADIOPHARMACEUTICALS MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 15 EUROPE RADIOPHARMACEUTICALS MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 16 EUROPE RADIOPHARMACEUTICALS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 17 EUROPE RADIOPHARMACEUTICALS MARKET: BY APPLICATION, 2022
FIGURE 18 EUROPE RADIOPHARMACEUTICALS MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 19 EUROPE RADIOPHARMACEUTICALS MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 20 EUROPE RADIOPHARMACEUTICALS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 21 EUROPE RADIOPHARMACEUTICALS MARKET: BY SOURCE, 2022
FIGURE 22 EUROPE RADIOPHARMACEUTICALS MARKET: BY SOURCE, 2023-2030 (USD MILLION)
FIGURE 23 EUROPE RADIOPHARMACEUTICALS MARKET: BY SOURCE, CAGR (2023-2030)
FIGURE 24 EUROPE RADIOPHARMACEUTICALS MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 25 EUROPE RADIOPHARMACEUTICALS MARKET: BY END USER, 2022
FIGURE 26 EUROPE RADIOPHARMACEUTICALS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 27 EUROPE RADIOPHARMACEUTICALS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 28 EUROPE RADIOPHARMACEUTICALS MARKET: BY END USER, LIFELINE CURVE
FIGURE 29 EUROPE RADIOPHARMACEUTICALS MARKET: SNAPSHOT (2022)
FIGURE 30 EUROPE RADIOPHARMACEUTICALS MARKET: BY COUNTRY (2022)
FIGURE 31 EUROPE RADIOPHARMACEUTICALS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 32 EUROPE RADIOPHARMACEUTICALS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 33 EUROPE RADIOPHARMACEUTICALS MARKET: BY TYPE (2023-2030)
FIGURE 34 EUROPE RADIOPHARMACEUTICALS MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
